HeraMED (HMD.AX) Stock Price

HeraMED Price

ASX·CLOSED
0.04
​
Market closed

Revenue has compounded at 29.5% per year over the past 6 years to 364,300.00 AUD. HeraMED's net margin stands at -1,507.2%, up from -8,503.8% several years earlier.

HeraMED stock price

Access this data via the Eulerpool API

HeraMED business model & stock analysis

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.

Frequently asked questions about HeraMED

Converted at the current exchange rate, the HeraMED share trades at 0.02 EUR (0.04 AUD).

The HeraMED share (HMD.AX) is listed on 2 stock exchanges, including: ASX (HMD.AX), Frankfurt (1I4.F).

The revenue cannot currently be calculated for HeraMED.

The profit cannot currently be calculated for HeraMED.

The P/E ratio cannot be calculated for HeraMED at the moment.

The P/S cannot be calculated for HeraMED currently.

The Eulerpool Quality Score for HeraMED is 3/10.

The ISIN of HeraMED is AU0000028367. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of HeraMED is A2PQND. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of HeraMED is HMD.AX. The ticker symbol is used to trade HeraMED shares on the stock exchange.

Fair ValueTerminal
0.03 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website hera-med.com
Country
Israel
Currency
AUD
Initial public offering
Dec 12, 2018
ISIN
AU0000028367
Cusip
Q45847102
Market capitalization
40.09 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
14.47
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-187.51 %
Last updated Oct 14, 2026, 2:32 AM

HeraMED Peer Group

HeraMED Ticker

ASX · HMD.AXFRANKFURT · 1I4.F

HeraMED FIGI

HMD:AU · BBG00MH6SMC7HMD:AT · BBG00MH6SMD6HMD:AH · BBG00MH6SMJ01I4:GR · BBG00Q42N2B11I4:GF · BBG00Q42N2C01I4:GS · BBG00Q42N2H5HMDEUR:XS · BBG00Q4WJRT6HMDEUR:XF · BBG00Q4WJRZ9HMDEUR:XE · BBG00Q4WJS14HMDEUR:XJ · BBG00Q4WJS23HMDEUR:XL · BBG00Q4WJS32HMDEUR:XG · BBG00Q4WJS41

All fundamentals and in-depth analysis of HeraMED

Our stock analysis for HeraMED stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HeraMED. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.